Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity
Summary: CANTOS (Canakinumab Antiinflammatory Thrombosis Outcome Study) confirmed interleukin (IL)–1β as an appealing therapeutic target for human atherosclerosis and related complications. However, there are serious gaps in our understanding of IL-1 production in atherosclerosis. Herein the authors...
Main Authors: | Xintong Jiang, MD, Feilong Wang, MD, Yajuan Wang, MD, PhD, Anton Gisterå, MD, PhD, Joy Roy, MD, PhD, Gabrielle Paulsson-Berne, PhD, Ulf Hedin, MD, PhD, Amir Lerman, MD, Göran K. Hansson, MD, PhD, Joerg Herrmann, MD, Zhong-qun Yan, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | JACC: Basic to Translational Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X19300683 |
Similar Items
-
Associations of Interleukin-5 With Plaque Development and Cardiovascular Events
by: Anki Knutsson, PhD, et al.
Published: (2019-12-01) -
Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis
by: Jianting Yao, MD, PhD, et al.
Published: (2020-01-01) -
Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell–Mediated Mechanism
by: Mizanur Rahman, PhD, et al.
Published: (2019-08-01) -
Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles?
by: Konstantinos Toutouzas, MD, PhD, et al.
Published: (2016-11-01) -
Polyarthritis, neuropathy, and persistent violaceous plaques
by: Alexander Ladenheim, MD, et al.
Published: (2021-09-01)